Sulfated β-Cyclodextrin-Mediated Antimicrobial Peptide Nanoparticles for Alkaloid Encapsulation
The β-cyclodextrin bearing an average of 13 sulfate groups (S13βCD) uniquely combines two key functions: it binds pharmaceutically relevant alkaloids
Category: Drug delivery
CDs for Regulating Cholesterol Homeostasis in Atherosclerosis
The progression of atherosclerosis (AS) is strongly linked to lipid crystals accumulation caused by cholesterol metabolism disorders and the worsening
Remdesivir (GS-5734) protects African green monkeys (AGM) from Nipah virus challenge
Introduction: Nipah virus is an emerging pathogen in the Paramyxoviridae family, which appers today a real threat for eventual pandemy.
Subcutaneous injection of an SBECD salt of ketamine
Conventional ketamine hydrochloride solutions are acidic and hyperosmotic, limiting their tolerability for subcutaneous (SC) delivery. BB106 is a novel ketamine
Poly(β-cyclodextrin)-coated dysprosium-doped ZnS nanocarriers
This study provides a comprehensive analysis of the structures and properties of zinc sulfide (ZnS) and dysprosium-doped ZnS nanoparticles (NPs)
Water-Soluble EDTA-Crosslinked Poly-β-Cyclodextrins as Ion-Complexing Drug Carriers.
Water-soluble poly-β-cyclodextrins (PCDs), crosslinked with ethylenediaminetetraacetic acid dianhydride (EDTADA), were synthesized at varying β-CD:EDTADA molar ratios (1:6, 1:9, 1:12, 1:15)
Special issue: Bioadhesive Nanocarriers: Innovations in Drug Release and Therapeutic Effectiveness
Bioadhesive nanocarriers are a notable field for drug delivery, standing out for their ability to combine the advantages of nanotechnology
Cyclodextrin-Based Niosomal Delivery of Imatinib
Lung cancer remains a significant cause of cancer-related deaths globally. The effective cancer treatment aims to deliver drugs that specifically
pH-responsive magnetic cyclodextrin-liposome nanoplatforms for stabilization and targeted delivery of topotecan
Topotecan (TPT), a potent anticancer agent, suffers from rapid hydrolysis of its active lactone ring under physiological conditions, severely limiting
Cyclodextrin-Driven Drug Deaggregation
The poor aqueous solubility of niclosamide (Nic), a drug with broad therapeutic potential beyond its original antiparasitic use, presents a